REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Coherus Oncology, Inc. (CHRS) on Wednesday reported a loss of $20.6 million in its second quarter.

The Redwood City, California-based company said it had a loss of 13 cents per share. Losses, adjusted for one-time gains and costs, were 19 cents per share.

The drug developer posted revenue of $14.3 million in the period, which missed Street forecasts. Three analysts surveyed by Zacks expected $26.3 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CHRS at https://www.zacks.com/ap/CHRS